A new study has revealed that tough liver cancer (Hepatocellular Carcinoma) can now be tackled by adoptive T-cell therapy. This new therapeutic approach in the treatment of HCC could be very important as without treatment the 5 year survival rate is just 5%. Globally, HCC accounts for 746,000 deaths, and in the UK alone is responsible for over 4,000 deaths per year. Glypican-3 (GPC3) is a tumour associated antigen expressed in up to 70% of HCC but not ...Friday 11 April 2014
Tough Liver Cancer to Now be Tackled by Immunotherapy
A new study has revealed that tough liver cancer (Hepatocellular Carcinoma) can now be tackled by adoptive T-cell therapy. This new therapeutic approach in the treatment of HCC could be very important as without treatment the 5 year survival rate is just 5%. Globally, HCC accounts for 746,000 deaths, and in the UK alone is responsible for over 4,000 deaths per year. Glypican-3 (GPC3) is a tumour associated antigen expressed in up to 70% of HCC but not ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment